Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Datascope, a medical device company, has signed a definitive agreement providing for the acquisition by Getinge, a medical technology company with existing operations in the cardiac and vascular surgery markets, for all of the outstanding shares of Datascope common stock for $53 per share.
Subscribe to our email newsletter
The transaction is subject to customary conditions, including the tender of a majority of the outstanding shares of Datascope common stock into the tender offer, regulatory approvals and the absence of a material adverse change with respect to Datascope.
Lawrence Saper, the chairman and CEO of Datascope and an 18% stockholder, has entered into a voting and tender agreement in connection with this transaction. Lehman Brothers acted as financial advisor to Datascope and Dechert acted as legal advisor.
Mr Saper said: “We are delighted that Datascope will be acquired by Getinge, a company that shares our commitment to serving the healthcare community. We believe that this transaction will deliver to our stockholders value at a historic high for our stock.”